Diabetic neuropathy is one of the commonest diabetic complications. It affects 30-50% of people with diabetes mellitus (DM) and may cause severe pain and foot ulcers. Distal symmetric polyneuropathy and diabetic autonomic neuropathy are the main manifestations of diabetic neuropathy. The American Diabetes Association's (ADA) 82nd Scientific Sessions took place in June 2022 in New Orleans, Louisiana, and the 58th European Association for the Study of Diabetes (EASD) Annual Meeting was held in September 2022 in Stockholm, Sweden. Herein, we describe interesting studies in the field of diabetic neuropathy presented in these two meetings.
BlairYDohertyLTemprosaM, et al.86-OR: Erectile dysfunction in men with prediabetes and type 2 diabetes: the diabetes prevention program outcomes study (DPPOS). Diabetes. 2022;71(Suppl 1):86-OR.
5.
GuptaPDohertyLTemprosaM, et al.87-OR: Female sexual dysfunction and type 2 diabetes: results from the diabetes prevention program outcomes study (DPPOS). Diabetes. 2022;71(Suppl 1):87-OR.
6.
TsatsarisGRajamand EkbergNFallTCatrinaS. Prevalence, incidence and risk factors for Charcot foot in patients with diabetes: a nationwide Swedish study. Diabetologia. 2022;65(Suppl 1):S19.
7.
MizrakHAmadidHRossingPVistisenDHansenC. Declining incident rates of distal polyneuropathy in a cohort study, but with distinct age-related patterns between diabetes types in the period 1996-2018. Diabetologia. 2022;65(Suppl 1):S190.
8.
NathanDMGroupDER. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care. 2014;37(1):9‐16. doi:10.2337/dc13-2112.
9.
BraffettBEl ghormliLAlbersJW, et al.Painful diabetic peripheral neuropathy in type 1 diabetes in the Epidemiology of Diabetes Interventions and Complications (EDIC) study. Diaabetologia. 2022;65(Suppl 1):S187.
10.
BrownleeM. The pathobiology of diabetic complications: a unifying mechanism. Diabetes Jun. 2005;54(6):1615‐1625. doi:10.2337/diabetes.54.6.1615
11.
OsonoiSMizukamiHOgasawaraSKudohKDaimonMYagihashiS. 80-OR: proinflammatory macrophage impairs retrograde axonal transport via inflammation and insulin resistance in sensory neurons. Diabetes. 2022;71(Suppl 1):80-OR.
12.
BlaszkiewiczMTownsendKL. 21-LB: Transdermal microneedle device delivery of adipocytespecific AAVs to overexpress adipose tissue neurotrophic factors in the treatment of diabetic peripheral neuropathy. Diabetes. 2022;71(Suppl 1):21-LB.
13.
QuGBWangLLTangXWuWSunYH. The association between vitamin D level and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus: an update systematic review and meta-analysis. J Clin Transl Endocrinol. 2017;9:25‐31.
14.
YangYWangJDingYZhangL. Serum 25-hydroxyvitamin D levels in relation to the risk of peripheral neuropathy in Chinese patients with type 2 diabetes. Diabetologia. 2022;65(Suppl 1):S715.
15.
Pop-BusuiRAngLGunaratnamS, et al.Inflammatory markers and cardiovascular autonomic neuropathy in type 1 diabetes. Diabetologia. 2022;65(Suppl 1):S710.
16.
AngLGunaratnamSHuangY, et al.458-P: Inflammatory markers and cardiovascular autonomic neuropathy in type 1 diabetes. Diabetes. 2022;71(Suppl 1):458-P.
17.
Ferreira-AtuestaCReyesSGiovanonniGGnanapavanS. The evolution of neurofilament light chain in multiple sclerosis. Front Neurosci. 2021;15:642384.
18.
MaalmiHStromAHauckSM, et al.81-OR: High throughput proteomics identifies neurofi light chain (NFL) as a novel blood biomarker for detection of diabetic sensorimotor polyneuropathy. Diabetes. 2022;71(Suppl 1):81-OR.
19.
Na JangHMoonSHo MoonJ, et al.462-P: Improvement of cardiovascular autonomic neuropathy after metabolic bariatric surgery in Korean subjects with obesity. Diabetes. 2022;71(Suppl 1):462-P.
20.
JinJ. 777-P: Short-term continuous subcutaneous insulin infusion treatment improves peripheral autonomic neuropathy in type 2 diabetes. Diabetes. 2022;71(Suppl 1):777-P.
21.
PetersenEStaussTGScowcroftJA, et al.22-LB: 24-month results for 10-khz spinal cord stimulation (SCS) in treating painful diabetic neuropathy (PDN). Diabetes. 2022;71(Suppl 1):22-LB.
22.
PetersenEStaussTGScowcroftJA, et al.Evidence of significant reduction in pain and sensory symptoms of diabetic neuropathy with 10 kHz spinal cord stimulation: 24-month RCT outcomes. Diabetologia. 2022;65(Suppl 1):S53.
23.
TehKSloanGPWilkinsonIDTesfayeSSelvarajahD. 84-OR: responders to neuropathic pain treatment have greater target engagement of opioid receptor systems: a resting state functional magnetic resonance imaging study in painful diabetic neuropathy. Diabetes. 2022;71(Suppl 1):84-OR.
24.
SelvarajahDTehKMcallisterJ, et al.Better target engagement of opioid receptor systems in responders to neuropathic pain treatment: a neurotransmitter-enriched functional connectivity mapping study. Diabetologia. 2022;65(Suppl 1):S189.
25.
PetrovaNLBanatwallaRHuntKF, et al.Onset of an active Charcot foot in a person with longstanding type 1 diabetes and normal vibration perception threshold-a case report. Int J Low Extrem Wounds. 2023;15347346231166550. Online ahead of print. doi:10.1177/15347346231166550
26.
ViswanathanVAhmed KhanBNachimuthuSKumpatlaS. Precision of Michigan Neuropathy Screening Instrument (MNSI) Tool for the diagnosis of diabetic peripheral neuropathy among people with type 2 diabetes-A study from South India. Int J Low Extrem Wounds. 2023;15347346231163209. Online ahead of print. doi:10.1177/15347346231163209
27.
KarakousisNDPyrgiotiEEGeorgakopoulosPNPapanasN. Vitamin b12 and diabetic foot: a mini-review. Int J Low Extrem Wounds. 2022;15347346221143018. Online ahead of print. doi:10.1177/15347346221143018
